Back

Separate roles of LMAN1 and MCFD2 in ER-to-Golgi trafficking of factor V and factor VIII

Zhang, Y.; Liu, Z.; Zhang, B.

2022-09-26 cell biology
10.1101/2022.09.25.509417 bioRxiv
Show abstract

Mutations in LMAN1 and MCFD2 cause the combined deficiency of FV and FVIII (F5F8D). LMAN1 and MCFD2 form a protein complex that transport FV and FVIII from the endoplasmic reticulum to the Golgi. Although both proteins are required for the cargo receptor function, little is known about specific roles of LMAN1 and MCFD2 in transporting FV/FVIII. We used different LMAN1 and MCFD2 deficient cell lines to investigate the LMAN1/MCFD2-dependent FV/FVIII secretion pathway. LMAN1 deficiency led to more profound decreases in FV/FVIII secretion in HEK293T and HepG2 cells than in HCT116 cells, suggesting regulation of cargo transport by the LMAN1/MCFD2 pathway varies in different cell types. Using these cell lines, we developed functional assays to accurately assess pathogenicity of recently reported potential LMAN1 and MCFD2 missense mutations. LMAN1 with mutations abolishing carbohydrate binding can still partially rescue FV/FVIII secretion, suggesting that N-glycan binding is not absolutely required for FV/FVIII transport. Surprisingly, overexpression of either WT or mutant MCFD2 is sufficient to rescue FV/FVIII secretion defects in LMAN1 deficient cells. These results suggest that cargo binding and transport are carried out by MCFD2 and that LMAN1 primarily serves as a shuttling carrier of MCFD2. Finally, overexpression of both LMAN1 and MCFD2 does not further increase FV/FVIII secretion, suggesting that the amount of the LMAN1-MCFD2 receptor complex is not a rate-limiting factor in ER-Golgi transport of FV/FVIII. This study provides new insight into the molecular mechanism of F5F8D and intracellular trafficking of FV and FVIII. Key PointsO_LIEfficient ER-to-Golgi transport of FV and FVIII requires the LMAN1-MCFD2 cargo receptor complex. C_LIO_LIMCFD2 functions as a primary interacting partner of FV/FVIII cargo and LMAN1 primarily serves as a shuttling carrier of MCFD2. C_LI

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
PLOS ONE
4510 papers in training set
Top 12%
14.7%
2
Glycobiology
30 papers in training set
Top 0.1%
10.3%
3
Human Mutation
29 papers in training set
Top 0.1%
7.0%
4
Journal of Biological Chemistry
641 papers in training set
Top 0.3%
4.4%
5
Blood
67 papers in training set
Top 0.4%
4.1%
6
G3 Genes|Genomes|Genetics
351 papers in training set
Top 0.6%
3.7%
7
Journal of Thrombosis and Haemostasis
28 papers in training set
Top 0.2%
3.0%
8
Journal of Virology
456 papers in training set
Top 2%
2.7%
9
Frontiers in Cell and Developmental Biology
218 papers in training set
Top 2%
2.7%
50% of probability mass above
10
Scientific Reports
3102 papers in training set
Top 45%
2.7%
11
The Journal of Immunology
146 papers in training set
Top 0.6%
2.1%
12
PLOS Genetics
756 papers in training set
Top 7%
1.9%
13
Molecular Biology of the Cell
272 papers in training set
Top 1%
1.9%
14
PLOS Computational Biology
1633 papers in training set
Top 14%
1.9%
15
International Journal of Molecular Sciences
453 papers in training set
Top 7%
1.7%
16
Journal of Cell Science
353 papers in training set
Top 1%
1.7%
17
eLife
5422 papers in training set
Top 45%
1.5%
18
Biochemical and Biophysical Research Communications
78 papers in training set
Top 0.8%
1.4%
19
Frontiers in Immunology
586 papers in training set
Top 6%
1.0%
20
JCI Insight
241 papers in training set
Top 6%
0.9%
21
Biology Open
130 papers in training set
Top 2%
0.9%
22
The FASEB Journal
175 papers in training set
Top 3%
0.8%
23
Cells
232 papers in training set
Top 5%
0.8%
24
Angiogenesis
15 papers in training set
Top 0.2%
0.8%
25
British Journal of Haematology
15 papers in training set
Top 0.4%
0.8%
26
Biophysical Journal
545 papers in training set
Top 4%
0.8%
27
PLOS Pathogens
721 papers in training set
Top 9%
0.8%
28
Frontiers in Physiology
93 papers in training set
Top 6%
0.7%
29
The American Journal of Pathology
31 papers in training set
Top 0.5%
0.7%
30
Cytoskeleton
23 papers in training set
Top 0.4%
0.7%